Real-time enrollment status for this kras-mutant non-small cell lung cancer (nsclc) clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 2:35 AM UTC
| NCT Number | NCT07458347 |
| Recruiting Status | Recruiting |
| Condition | KRAS-mutant Non-small Cell Lung Cancer (NSCLC) |
| Phase | PHASE1 |
| Target Enrollment | 145 participants |
| Active Locations | 9 sites in the US |
| Sponsor | Kestrel Therapeutics, Inc. |
| Last Updated on CT.gov | June 29, 2026 (Jun 29, 2026) |
As of August 28, 2026: Clinical trial NCT07458347 is currently recruiting participants. This phase1 study for kras-mutant non-small cell lung cancer (nsclc) is actively seeking new participants at 9 locations across the United States. The study is sponsored by Kestrel Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07458347 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07458347 was last updated Jun 29, 2026 (June 29, 2026). HelloStudys verifies this status automatically.